Raily Aesmed (02135) has released an announcement indicating that the group expects to report a loss of approximately RMB 2 million for the year ending December 31, 2025. This compares to a loss of about RMB 63 million for the year ended December 31, 2024. The group also anticipates an attributable profit to owners of approximately RMB 2 million for the year ending December 31, 2025, a significant improvement from an attributable loss of roughly RMB 59 million in the previous year. The board attributes the expected improvement in the 2025 financial results primarily to a one-off impairment loss recorded in 2024, which is not present in 2025. An enhancement in the overall business profit margin also contributed to the improved performance for 2025.